Skip to main content

Vivek Ramaswamy

< Back to previous page

Vivek Ramaswamy

Founder and CEO, Roivant Sciences
Vivek Ramaswamy

Vivek Ramaswamy is the Founder and Chief Executive Officer of Roivant Sciences, a healthcare company focused on unlocking innovation in medicine. Roivant builds and operates "Vants" - nimble, entrepreneurial biotech and health technology companies with a unique approach to sourcing talent, aligning economic incentives, and deploying technology to drive greater efficiency in R&D. Roivant has over 800 employees and over 35 investigational medicines in development across its family of companies and has raised over $3 billion in capital to support its mission. Prior to founding Roivant in 2014, Mr. Ramaswamy was a successful investor in the biotechnology sector where he oversaw investment in a curative treatment regimen for hepatitis C virus. He received his A.B. summa cum laude in Biology from Harvard College and his J.D. from Yale Law School, where he was a Paul & Daisy Soros Fellow.